practical skills for life science entrepreneurs

foundations 2015



free + open course

Foundations is designed to provide new entrepreneurs with an understanding of the innovation process, teaching them how to evaluate a life science technology as the basis for starting a new business. Learn how you can turn your creativity loose to design the future of healthcare. Whether you're an engineer, scientist, physician, or business expert, this class will bring you up to speed on the medical innovation industry.

Go to the current foundations series

sign up for our newsletter to receive updates



Tue, May 26
The Innovation Process:
Confessions of a Wantrepreneur

Do you think like an entrepreneur? Here we'll discuss how to actively observe your environment for clinical needs which can be adressed with marketable solutions. We'll also consider active brainstorming methods, useful for when the entrepreneur already has a pain point but not the solution. For those of you with too many ideas and not enough time, we'll discuss how to narrow down concepts to the one with the best value proposition.

  • Who can be an entrepreneur? Inventor vs Method entrepreneurs
  • Where do great ideas come from? Indicators of a clinical need
  • How to evaluate which problems are worth solving


Wed, June 24
Market & Competitive Analysis:
Nobody Cares about your "Cool Tech"

You have a great idea, but how do you know if you can build a company from it? Here, we discuss how to define and target the customers in your target market. What do your customers really need, and are those needs being met already? We'll also discuss how to map out the competitive landscape, how to disrupt that landscape, and how you yourself could be disrupted. Finally, we'll identify key the key stakeholders and their needs, as well as how those needs may be in direct conflict with your other stakeholders.

  • How do you define your market? Are you addressing their needs?
  • Who are the key stakeholders?
  • How do you do a competitive analysis?


Wed, July 15
Startup Structure: Building Your Company with Limited Resources

In this session, we'll discuss the basics of forming and structuring a company. What kind of people should you hire early and which roles can wait until your company is more mature? How do you pay people and how much equity do you give your earliest employees? During this workshop, you'll work with a team to divide up a company among founders, employees, and investors.

  • Dividing Equity
  • Startup Roles
  • Resource Allocation


Wed, August 5
Startup Deals: What To Ask For and What You're Worth

We'll discuss how to define key milestones that will create the most value for your company and reduce your risk. We'll also cover the most common sources of funding for your company, which can come in non-dilutive and dilutive forms. Finally, we'll walk you through the key components of a term sheet so you can be smarter than your investors.

  • How much is your company worth?
  • Defining milestones that create value
  • Mitigating risk
  • Key components of the Term Sheet
  • Funding sources and investment types


Wed, August 26
Patents & Intellectual Property

Here, we'll go over what is patentable, the different types of patents, and how to conduct a basic patent search on your own, as well as when you should be bringing in legal expertise. We'll also discuss what a patent really earns you, and what it does not. Finally, if you work within an instituion being the inventor does not give you ownership of the intellectual property. We'll discuss here how to go about licensing a technology from an institution.


Wed, October 7
Regulatory & Clinical Strategy

Sure, your invention is amazing, and your business plan is solid, but before your product ever reaches a patient, you need to get regulatory approval. We'll introduce you to Allison Komiyama, a former FDA reviewer and discuss what it's like dealing with the FDA today (hint: it's not as bad as you think). We'll also cover strategies for getting approval outside the US and how your path might be different depending on whether you're in Health IT, Med Devices, Biotech, or Pharma.

  • Regulatory Timelines
  • Navigating FDA Guidance
  • Drugs vs Devices vs Heath IT
  • Case Studies


Wed, December 9

Before you ever sell to a single customer, you'll have to pitch your startup to investors, partners, and potential employees. We'll discuss the key elements of a great pitch whether it is a one-liner, elevator pitch, or a full slide deck for investors. How do you tailor your talk to the audience? What do they want to know? We'll wrap up with a quick elevator pitch competition, where your team will have 90 seconds to deliver a pitch.


Speakers for Foundations have been selected from the pool of local entrepreneurs in and around the Houston area, having seen their ability to mentor startups firsthand. We believe that these early to mid-career mentors are the best resource for young and aspiring entrepreneurs. These mentors are where we want you all to be in 5-10 years. Our hope is that you make a real and lasting connection to at least one of these lecturers during the Foundations course.

  • Collin Brack, MBA
    Collin Brack, MBA
    President - HLA Data Systems

    Collin is a technology executive with over 15 years of experience in technology management, leadership and operations within the Healthcare and Energy sectors. He has been a business development and product strategy advisor to many early-stage companies. Collin's expertise is advising corporate leadership and entrepreneurs on business development strategies and emerging technology trends that drive the bottom line, including recent shifts to cloud-computing, SaaS revenue models, and data monetization.

  • Imran Alibhai, PhD
    Imran Alibhai, PhD
    Managing Director at DNAtrix, Inc.

    Imran Alibhai serves as the Managing Director of the Houston office of DNAtrix. Prior to DNAtrix, he was an investment banker in Peter J. Solomon Company’s Healthcare Advisory Group, focused on M&A transactions in science based markets including biopharmaceuticals, medical devices/diagnostics and life science tools. Previously, he was the Senior Director of Alexandria Venture Investments, where he was responsible for the firm’s investments in emerging companies and funds in the healthcare sector. He also directed investments for PIPE’s and long/short positions in MPM Capital’s BioEquities hedge fund. Imran began his career in early stage venture capital at the Accelerator Corp., where he was involved in every facet of company / project formation and management. Imran holds a Ph.D. in Molecular Neuroscience from the University of Texas Southwestern Medical School and a B.S. in Biology from Duke University.

  • Bryan Haardt, MBA
    Bryan Haardt, MBA
    CEO - Decisio Health

    Bryan Haardt has more than 15 years of combined information technology, management, and consulting experience. Mr. Haardt is the Co-Founder and Chief Executive Officer of Decisio Health, Inc., an early-stage Healthcare IT company initially focusing on clinical decision support for trauma and emergency medicine.

    Prior to forming Decisio, Mr. Haardt served as the Chief Operating Officer for Prognosis Health Information Systems, Inc. In addition, Mr. Haardt was the founder and CTO of Cgate Health, Inc., a DFJ Mercury portfolio company. Mr. Haardt began his career as the founder and President of 10X Labs, Inc. 10X Labs was the first company to be admitted into the Intel Incubation Program and counted Compaq amongst its investors. Mr. Haardt graduated Cum Laude from the University of Houston where he was a distinguished student and member of the Honors College studying artificial intelligence and neural-networks.

    Mr. Haardt was a founding member of the Greater Houston Partnership’s Emerging Business Council where he was active in promoting new business growth in the city of Houston. Mr. Haardt served as the CTO for the Houston Technology Center and provided technology consulting and deal evaluation for a number of technology-focused venture capital firms including Draper Fisher Jurvetson. Mr. Haardt is currently an adjunct professor at Rice Universities Jones Graduate School of Business, an advisory board member of the Rice Alliance I.T. and Web Venture forum, and a judge for the prestigious Rice business plan competition.

  • Gray Hancock, MBA
    Gray Hancock, MBA
    COO - Decisio Health

    Gray is the Co-Founder and Chief Operating Officer of Decisio Health, Inc. Decisio Health provides an FDA cleared class II medical device that displays real-time actionable information with the goal of increasing clinical guideline adherence, which has been shown to improve clinical outcomes and reduce hospital costs.

    Gray was the Head of Trade and Investment for UK Trade and Investment (UKTI) in Houston, Texas. Previously, Gray was the Director of Operations for DNAtrix, Inc., an early-stage biotechnology company incubated out of the Mercury Fund in Houston, TX. Gray handled issues surrounding intellectual property strategy, capital raising, regulatory management, licensing, board recruitment, corporate governance and day-to-day operations.

    Gray’s educational background includes an MBA from the Rice University Jones Graduate School of Management, a Masters of Public Health from the UT School of Public Health, and a BS in Biology from Washington and Lee University. Gray sits on the Roundtable Advisory Board for the Rice Alliance for Technology and Entrepreneurship and the Board of Directors of the British American Business Council. Gray also has a faculty appointment at Rice University Jones Graduate School of Management as an Adjunct Professor where he has taught Technology Entrepreneurship.

  • Tim Shen, JD
    Tim Shen, JD
    Tim Shen Consulting, LLC

    Tim Shen is an intellectual property attorney with over 20 years of experience in the areas of intellectual property law, contracts and licensing, and technology research and development.

    Before starting his own law office, Tim practiced law at the international law firm of Baker Botts and then served as senior IP counsel for BMC Software. In his first career, Tim worked as a computer engineer in enterprise systems management and programming.

    In addition, Tim is the supervising attorney for the Trademark Clinic at South Texas College of Law in Houston, which provides free trademark assistance to individuals and small companies. In the last three years under Tim’s supervision, the Trademark Clinic has served over 100 clients nationwide.

  • Allison Komiyama, PhD, RAC
    Allison Komiyama, PhD, RAC
    AcKnowledge Regulatory Strategies

    Allison is a former FDA reviewer who is an expert in regulatory submissions, quality systems, and biocompatibility evaluation. She started AcKnowledge Regulatory Strategies in order to serve clients who manufacture implantable and other patient-contacting medical devices. She received her Ph.D. in Neuroscience from Stanford University and her B.A. in Molecular and Cell Biology from University of California, Berkeley.

    While working at FDA as a biologist and reviewer in the Office of Device Evaluation, she acted as a lead reviewer and consult on 510(k) Premarket Notifications, Investigational Device Exemption (IDE) applications and Premarket approval (PMA) submissions. Her specialty was in biocompatibility requirements for implanted devices. She also researched neurotoxicity and systemic toxicity of medical devices in the Office of Science and Engineering Labs in support of FDA recognized ISO and ASTM standards. After her time at FDA, she worked as a project manager and regulatory affairs manager at an in vitro diagnostic device company, as well as a senior regulatory specialist and director of regulatory affairs at two boutique consulting firms.

  • Benjamin A. Hertzog, PhD
    Benjamin A. Hertzog, PhD
    President & CEO, Procyrion

    Experienced start-up entrepreneur with a focus on medical devices, diagnostics and healthcare services. Raised over $12M for med device startup, Procyrion. Managing Director of AlphaDev LLC; Vice President of BCM Technologies; McKinsey & Co. (Member of Pharmaceutical and Medical Products Practice); Ph.D. from Brown University’s Artificial Organs, Biomaterials, and Cellular Technology program; Previous corporate Board seats include Medical Metrics, Fairway Medical Technologies, Spectral Genomics (acquired by Perkin Elmer) and Kardia Therapeutics (founding president).